Navigation Links
Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD
Date:10/29/2008

- Study showed no consistent differences in bone mineral density at the lumbar spine and total hip between Advair Diskus 250/50 (fluticasone propionate and salmeterol inhalation powder) and salmeterol

- Study provides support for long term use of Advair(R) in patients with COPD

PHILADELPHIA, Oct. 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that data from a three-year study of patients with Chronic Obstructive Pulmonary Disease (COPD) found that the inhaled corticosteroid in Advair Diskus 250/50, fluticasone propionate, did not show an adverse effect on bone mineral density (BMD) measured at the lumbar spine and total hip compared to salmeterol alone. In this study, designed to show equivalent rate of change in BMD for Advair and salmeterol, results for bone mineral density in the lumbar spine did not meet clinical equivalence although the rate of change favored Advair. The data was presented in Philadelphia at CHEST 2008, the annual meeting of the American College of Chest Physicians.

"These data are very encouraging for patients with COPD since most patients with this debilitating disease are at an age where they may also be at risk for bone loss," said Richard ZuWallack, MD of St. Francis Hospital and Medical Center, Hartford CT. "These data inform on the long-term impact of inhaled corticosteroids on bone mineral density."

About the Study

Effects of treatment with Advair Diskus 250/50 or salmeterol 50 mcg on BMD were evaluated in 186 patients (females and males 43 to 87 years of age) with COPD in a 3-year double-blind study. BMD evaluations were conducted at baseline and at 6-month intervals. The study was designed to show equivalence in the rate of change of BMD at the L1-L4 lumbar spine and total hip between Advair and salmeterol (defined as a difference in BMD of +/-1% per year). The difference in the rate of change of BMD for Advair versus salmeterol at the lumbar spine was +0.8% per year
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
2. Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds
3. NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
4. Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference
5. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
6. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
7. Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
8. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
9. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
10. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
11. Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... January 15, 2014 BreedIT Corp (OTC: ... worldwide distributor of highly sophisticated agro-breeding solutions for plant ... 2014, the Company,s board of directors appointed chemistry and ... its new member of the board. From ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Calif. , April 23 PRO-DEX, INC. (Nasdaq: PDEX ) ... period ended March 31, 2010 on Thursday, April 29, 2010 ... , , ... Eastern Time ( 1:30 Pacific Time ) to discuss operating performance for ...
... VIENNA , April 23, 2010 ... progressed to phase II clinical testing.,It may therefore be possible ... 2012. Indeed the start of this efficacy study comes only ... The company,is active in several disease areas and is currently ...
Cached Medicine Technology:Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast 2Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast 3AFFiRiS AG: Alzheimer's Vaccine AD02 Already in Clinical Phase II 2AFFiRiS AG: Alzheimer's Vaccine AD02 Already in Clinical Phase II 3AFFiRiS AG: Alzheimer's Vaccine AD02 Already in Clinical Phase II 4
(Date:4/17/2014)... who show signs of chronic inflammation in non-cancerous prostate ... having prostate cancer than those with no inflammation, according ... from the Johns Hopkins Kimmel Cancer Center. , The ... for men with so-called high-grade prostate cancer those ... indicating the presence of the most aggressive and rapidly ...
(Date:4/17/2014)... One of the most popular vaccine brands for ... doctors may be overlooking some cost factors when choosing ... more expensive option, according to a new study by ... to administer can be driven by numerous factors," says ... a professor of computer science and of mathematics at ...
(Date:4/17/2014)... San Diego School of Medicine report that older women, ... major loss are more likely to be compassionate toward ... published in this month,s issue of the International ... are associated with better health and well-being as we ... improve the outcomes of individuals whose deficits in compassion ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... (April 17, 2014) Doctors who treat patients ... lymphangioleiomyomatosis (LAM) can face an agonizing treatment decision. ... the disease and help relieve shortness of breath. ... and sirolimus can cause potentially fatal complications following ... Dr. Daniel Dilling, medical director of Loyola University ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... Cardiac Science (Nasdaq: CSCX ), ... rehabilitation, and informatics products, today announced that it ... Association (WBBA) 2009 Invest Northwest CEO and Investor ... in Seattle. Michael Matysik, senior vice president and ...
... Nausea and Vomiting (PONV)CORONA DEL MAR, Calif., March 11 ... patient,s oxygen status known on a beat-by-beat basis. Not ... say that all patients should have this monitor. No ... ASA Newsletter on their web site between 1983 and ...
... Interactive, Inc. was accepted as an affiliate member of ACA International ... as the American Collectors Association. , ... (Vocus) March ... Ave Ste 100, Plantation, FL 33324-3223, was accepted as an affiliate ...
... Corporation with a Scalable, Powerful System in Support of Patient Safety ... ... Francisco, CA (PRWEB) March 11, 2009 -- The Florida Patient Safety ... certified as a Patient Safety Organization (PSO), has chosen Quantros ...
... a toy drive at Build-A-Bear during annual team-building event , ... ... Cydcor , the leading provider of outsourced, face-to-face sales teams, hosted ... annual corporate kick-off meeting. , ,About 70 participating Cydcor ...
... BC Decker Inc, publisher of the acclaimed general surgical reference, ACS ... MD, FACS as the new Editor-in-Chief , ... Philadelphia, ... the acclaimed general surgical reference, ACS Surgery, is honored to announce ...
Cached Medicine News:Health News:Cardiac Science to Present at the Eighth Annual Invest Northwest Conference 2Health News:American Society of Anesthesiologists (ASA) - Myths About 'Never Ending Pursuit of Patient Safety and Satisfaction' Debunked 2Health News:Business Becomes Affiliate Member of International Trade Association 2Health News:The Nation's First Federally Certified Patient Safety Organization Chooses Quantros Patient Safety Organization Manager 2Health News:The Nation's First Federally Certified Patient Safety Organization Chooses Quantros Patient Safety Organization Manager 3Health News:The Nation's First Federally Certified Patient Safety Organization Chooses Quantros Patient Safety Organization Manager 4Health News:The Nation's First Federally Certified Patient Safety Organization Chooses Quantros Patient Safety Organization Manager 5Health News:Cydcor Builds Bears and Bonds in Special Charity Event Benefitting Childrens Hospital Los Angeles 2Health News:New Editor, New Vision for ACS Surgery 2Health News:New Editor, New Vision for ACS Surgery 3
... For the qualitative ... falciparum (P.f) antigen and an ... all four species of malaria:plasmodium ... Plasmodium ovale (P.o) and Plasmodium ...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
... combines full 0.25 mm pb protection ... drape material that can be placed ... the clinician and the source of ... must be in very close proximity ...
... only insulin pen with a memory. HumaPen MEMOIR records ... doses (including priming doses). You can see exactly when ... MEMOIR, you simply "dial" your dose by turning the ... after initial set-up. If you dial too many units, ...
Medicine Products: